Lukas Clemens Böckelmann

6PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2025
6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

Tobias Busenbender, Dmitry N Pelageev, Jessica Hauschild

|Dec 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer.

Gunhild von Amsberg, Mirjam Zilles, Wael Mansour

|Feb 03, 2021
Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.

Tanja Spethmann, Lukas Clemens Böckelmann, Vera Labitzky

|Mar 04, 2020
Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells.

Lukas Böckelmann, Christin Starzonek, Ann-Christin Niehoff

|Dec 12, 2019
Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?

Lukas Clemens Böckelmann, Udo Schumacher

Pageof 1